Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Molecular Cancer Therapeutics|December 7, 2002
Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysisAkira Yokoi, Junro Kuromitsu, Takatoshi Kawai, et al.Nature Chemical Biology|July 24, 2007
Splicing factor SF3b as a target of the antitumor natural product pladienolideYoshihiko Kotake, Koji Sagane, Takashi Owa, et al.Analytical Chemistry|May 2, 2003
Quantitative chemical proteomics for identifying candidate drug targetsYoshiya Oda, Takashi Owa, Toshitaka Sato, et al.Biochemical and Biophysical Research Communications|November 27, 2021
NF-κB suppression synergizes with E7386, an inhibitor of CBP/β-catenin interaction, to block proliferation of patient-derived colon cancer spheroidsYusuke Kanda, Hirokazu Ohata, Toshiaki Miyazaki, et al.Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Synthesis and biological evaluation of N-(7-indolyl)-3-pyridinesulfonamide derivatives as potent antitumor agentsTakashi Owa, Hiroshi Yoshino, Tatsuo Okauchi, et al.Cancer|April 17, 2018
Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromeRita Assi, Hagop M Kantarjian, Tapan M Kadia, et al.Molecular Omics|March 24, 2020
β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinomaKevin Brown Chandler, Khalid A Alamoud, Vanessa L Stahl, et al.Nature Chemical Biology|April 25, 2017
Selective degradation of splicing factor CAPERα by anticancer sulfonamidesTaisuke Uehara, Yukinori Minoshima, Koji Sagane, et al.NPJ Precision Oncology|May 24, 2024
A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiencyShinji Kohsaka, Shigehiro Yagishita, Yukina Shirai, et al.Cancer Research|November 5, 2002
Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endotheliumYasuhiro Funahashi, Naoko Hata Sugi, Taro Semba, et al.Pageof 3